Bird CC, McElin TW, Manalo-Estrella P (1972) The elusive adenomyosis of the uterus–revisited. Am J Obstet Gynecol 112:583–593

Article  CAS  PubMed  Google Scholar 

Critchley HOD, Babayev E, Bulun SE, Clark S, Garcia-Grau I, Gregersen PK et al (2020) Menstruation: science and society. Am J Obstet Gynecol 223:624–664

Article  PubMed  PubMed Central  Google Scholar 

Taran FA, Stewart EA, Brucker S (2013) Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd 73:924–931

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tremellen K, Russell P (2011) Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment. Aust N Z J Obstet Gynaecol 51:280–283

Article  PubMed  Google Scholar 

Martinez-Conejero JA, Morgan M, Montesinos M, Fortuno S, Meseguer M, Simon C et al (2011) Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation. Fertil Steril 96:943–950

Article  PubMed  Google Scholar 

Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E (2014) Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod 29:964–977

Article  PubMed  Google Scholar 

de Bruijn AM, Lohle PN, Huirne JA, de Vries J, Twisk M, Group QU-T, Hehenkamp WJ. Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA trial. JMIR Res Protoc 2018; 7: e47.

Pontis A, D’Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S (2016) Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol 32:696–700

Article  CAS  PubMed  Google Scholar 

Harmsen MJ, Wong CFC, Mijatovic V, Griffioen AW, Groenman F, Hehenkamp WJK, Huirne JAF (2019) Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review. Hum Reprod Update 25:647–671

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52:237–268

Article  CAS  PubMed  Google Scholar 

Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31

Article  CAS  PubMed  Google Scholar 

Critchley HOD, Maybin JA, Armstrong GM, Williams ARW (2020) Physiology of the endometrium and regulation of menstruation. Physiol Rev 100:1149–1179

Article  PubMed  Google Scholar 

Girling JE, Rogers PA (2005) Recent advances in endometrial angiogenesis research. Angiogenesis 8:89–99

Article  PubMed  Google Scholar 

Li B, Chen M, Liu X, Guo SW (2013) Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide. Fertil Steril 100:568–577

Article  CAS  PubMed  Google Scholar 

Huang TS, Chen YJ, Chou TY, Chen CY, Li HY, Huang BS et al (2014) Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells. J Cell Mol Med 18:1358–1371

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Shen M, Qi Q, Zhang H, Guo SW (2016) Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod 31:734–749

Article  CAS  PubMed  Google Scholar 

Wang J, Deng X, Yang Y, Yang X, Kong B, Chao L (2016) Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis. Fertil Steril 105:1093–1101

Article  CAS  PubMed  Google Scholar 

Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, Petraglia F (2017) Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online 35:592–601

Article  CAS  PubMed  Google Scholar 

Kang S, Li SZ, Wang N, Zhou RM, Wang T, Wang DJ et al (2010) Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women. Hum Reprod 25:1806–1811

Article  CAS  PubMed  Google Scholar 

Yen CF, Huang SJ, Lee CL, Wang HS, Liao SK (2017) Molecular characteristics of the endometrium in uterine adenomyosis and its biochemical microenvironment. Reprod Sci 24:1346–1361

Article  CAS  PubMed  Google Scholar 

Harmsen MJ, Arduc A, Bleeker MCG, Juffermans LJM, Griffioen AW, Jordanova ES, Huirne JAF (2022) Increased angiogenesis and lymphangiogenesis in adenomyosis visualized by multiplex immunohistochemistry. Int J Mol Sci 23:8434

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

Article  CAS  PubMed  Google Scholar 

Thairu N, Kiriakidis S, Dawson P, Paleolog E (2011) Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis 14:223–234

Article  CAS  PubMed  Google Scholar 

Castermans K, Tabruyn SP, Zeng R, van Beijnum JR, Eppolito C, Leonard WJ et al (2008) Angiostatic activity of the antitumor cytokine interleukin-21. Blood 112:4940–4947

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S et al (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103:15975–15980

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dings RP, Chen X, Hellebrekers DM, van Eijk LI, Zhang Y, Hoye TR et al (2006) Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities. J Natl Cancer Inst 98:932–936

Article  CAS  PubMed  Google Scholar 

Wentink MQ, Hackeng TM, Tabruyn SP, Puijk WC, Schwamborn K, Altschuh D et al (2016) Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity. Proc Natl Acad Sci U S A 113:12532–12537

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tadayoni R, Sararols L, Weissgerber G, Verma R, Clemens A, Holz FG (2021) Brolucizumab: a newly developed Anti-VEGF molecule for the treatment of neovascular age-related macular degeneration. Ophthalmologica 244:93–101

Article  CAS  PubMed  Google Scholar 

Weiss A, van Beijnum JR, Bonvin D, Jichlinski P, Dyson PJ, Griffioen AW, Nowak-Sliwinska P (2014) Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization. J Cell Mol Med 18:480–491

Article  CAS  PubMed  PubMed Central  Google Scholar 

Green AR, Styles JA, Parrott EL, Gray D, Edwards RE, Smith AG et al (2005) Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol 56:255–263

Article  CAS  PubMed  Google Scholar 

Zhu B, Chen Y, Shen X, Liu X, Guo SW (2016) Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence. Reprod Biol Endocrinol 14:66

Article  PubMed